Structural variation analysis with and without a reference genome

有和没有参考基因组的结构变异分析

基本信息

  • 批准号:
    10436328
  • 负责人:
  • 金额:
    $ 36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-07 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Structural variations (SVs) analysis is very important because they are a major source of genetic variations and account for a wide range of phenotypes in many species. To better understand their contribution to diversity, divergence, and a variety of phenotypic traits, we should address two critical issues for SV analysis: accurate SV characterization and understanding their formation mechanisms. Without accurate SV results, we may miss the SV events that account for the phenotypes. Without understanding their formation mechanisms, we may not distinguish the phenotype associated SVs from other SVs. As the sequencing technology evolves, many new sequencing platforms such as PacBio, Oxford Nanopore, and 10X Genomics with longer sequencing reads appeared and have demonstrated great potential. However, the computational algorithms for SV analysis are inadequate for organisms both with and without a reference genome and SV mechanism analysis was merely based on short (<10bp mostly) breakpoint junction sequences due to technical limitations. As more of such data is being generated, there is an urgent need to fill in the gap by developing more accurate and efficient algorithms for SV discovery and establishing an innovative way to investigate SV formation mechanisms. The long-term goal of the laboratory is to comprehensively characterize all forms of SVs and understand their functional consequences and formation mechanisms. The goals of the next three years are to develop efficient algorithms to SV analysis for organisms both with and without a reference. We will focus on large insertions, inversions, and complex SVs which are always underrepresented. For organisms with a reference, we will develop a de novo assembly evaluation method to optimize existing tools and/or develop new assembly methods. Given these toolkits, the goals for the following two years are to study the SV formation mechanisms based on global genomic architecture. Our central hypothesis is that there may be some hotspots, signatures around the SV locus either inherited from paternal or maternal genomes causing the rearrangement formation susceptibility. We will test the hypothesis based on investigating a global and haplotype picture of SVs using the new sequencing platforms. It is expected that the research will contribute a suite of robust methods on the long-read sequencing data to identify all forms of SVs with high sensitivity and precision. Besides, it is expected that this work will provide novel insights into SV formation mechanisms. The proposed work is innovative in that the proposed computational approach will greatly improve the sensitivity and precision for SV detection using long sequencing reads under the circumstances of both with and without a reference genome. Also, the outcomes of this work may vertically advance the SV mechanism research. The proposed research is significant because it will facilitate the discovery of pathogenic variations and the establishment of the association between genotype and phenotype. It may also popularize the usage of new sequencing platforms to address novel scientific questions.
结构变异(SVs)是遗传变异的主要来源,因此对其进行分析是非常重要的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zechen Chong其他文献

Zechen Chong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zechen Chong', 18)}}的其他基金

Understanding the mechanisms of congenital hydrocephalus using genomic sequencing approaches
使用基因组测序方法了解先天性脑积水的机制
  • 批准号:
    10789333
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
  • 批准号:
    10029410
  • 财政年份:
    2020
  • 资助金额:
    $ 36万
  • 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
  • 批准号:
    10655596
  • 财政年份:
    2020
  • 资助金额:
    $ 36万
  • 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
  • 批准号:
    10212425
  • 财政年份:
    2020
  • 资助金额:
    $ 36万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了